Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Guiastrennec B"'
Autor:
Uenishi GI; GentiBio Inc, Cambridge, Massachusetts, USA., Repic M; GentiBio Inc, Cambridge, Massachusetts, USA., Yam JY; GentiBio Inc, Cambridge, Massachusetts, USA., Landuyt A; GentiBio Inc, Cambridge, Massachusetts, USA., Saikumar-Lakshmi P; GentiBio Inc, Cambridge, Massachusetts, USA., Guo T; GentiBio Inc, Cambridge, Massachusetts, USA., Zarin P; GentiBio Inc, Cambridge, Massachusetts, USA., Sassone-Corsi M; GentiBio Inc, Cambridge, Massachusetts, USA., Chicoine A; GentiBio Inc, Cambridge, Massachusetts, USA., Kellogg H; GentiBio Inc, Cambridge, Massachusetts, USA., Hunt M; Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, Washington, USA., Drow T; Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, Washington, USA., Tewari R; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA., Cook PJ; Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, Washington, USA., Yang SJ; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA., Cerosaletti K; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA., Schweinoch D; IntiQuan GmbH, Basel, Switzerland., Guiastrennec B; IntiQuan GmbH, Basel, Switzerland., James E; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA., Patel C; GentiBio Inc, Cambridge, Massachusetts, USA., Chen TF; GentiBio Inc, Cambridge, Massachusetts, USA., Buckner JH; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.; Department of Medicine.; Department of Immunology, and., Rawlings DJ; Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, Washington, USA.; Department of Immunology, and.; Department of Pediatrics, University of Washington, Seattle, Washington, USA., Wickham TJ; GentiBio Inc, Cambridge, Massachusetts, USA., Mueller KT; GentiBio Inc, Cambridge, Massachusetts, USA.
Publikováno v:
JCI insight [JCI Insight] 2024 Feb 08; Vol. 9 (6). Date of Electronic Publication: 2024 Feb 08.
Autor:
Guiastrennec, B1 guiastrennec@gmail.com, Sonne, DP2, Hansen, M2,3, Bagger, JI2, Lund, A2, Rehfeld, JF4, Alskär, O1, Karlsson, MO1, Vilsbøll, T2, Knop, FK2, Bergstrand, M1
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Dec2016, Vol. 5 Issue 12, p692-700. 9p.
Autor:
Li D; Merck & Co., Inc., Kenilworth, New Jersey, USA., Sabato PE; Merck & Co., Inc., Kenilworth, New Jersey, USA., Guiastrennec B; Certara, Data Science Services, Basel, Switzerland., Ouerdani A; Certara, Data Science Services, Paris, France., Feng HP; Merck & Co., Inc., Kenilworth, New Jersey, USA., Duval V; Certara, Data Science Services, Basel, Switzerland., De Anda CS; Merck & Co., Inc., Kenilworth, New Jersey, USA., Sears PS; Merck & Co., Inc., Kenilworth, New Jersey, USA., Chou MZ; Merck & Co., Inc., Kenilworth, New Jersey, USA., Hardalo C; Merck & Co., Inc., Kenilworth, New Jersey, USA., Broyde N; Merck & Co., Inc., Kenilworth, New Jersey, USA., Rizk ML; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Nov 17; Vol. 65 (12), pp. e0089521. Date of Electronic Publication: 2021 Sep 13.
Autor:
Maas BM; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Lommerse J; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Plock N; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Railkar RA; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Cheung SYA; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Caro L; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Chen J; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Liu W; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Zhang Y; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Huang Q; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Gao W; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Qin L; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Meng J; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Witjes H; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Schindler E; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Guiastrennec B; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Bellanti F; Certara, 100 Overlook Center STE 101, Princeton, NJ 08540, USA., Spellman DS; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Roadcap B; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Kalinova M; hVivo Services Ltd, 42 New Road, London E1 1JT, UK., Fok-Seang J; hVivo Services Ltd, 42 New Road, London E1 1JT, UK., Catchpole AP; hVivo Services Ltd, 42 New Road, London E1 1JT, UK., Espeseth AS; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Stoch SA; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Lai E; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Vora KA; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Aliprantis AO; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA., Sachs JR; Merck & Co., Inc., 2000 Galloping Hill Rd, Kenilworth, NJ 07033, USA. Electronic address: jeff_sachs@merck.com.
Publikováno v:
EBioMedicine [EBioMedicine] 2021 Nov; Vol. 73, pp. 103651. Date of Electronic Publication: 2021 Nov 11.
Autor:
Stage TB; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.; Pharmacometrics Group, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Wellhagen G; Pharmacometrics Group, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Christensen MMH; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark., Guiastrennec B; Pharmacometrics Group, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Brøsen K; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark., Kjellsson MC; Pharmacometrics Group, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Publikováno v:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2019 Jan; Vol. 124 (1), pp. 105-114. Date of Electronic Publication: 2018 Oct 30.
Autor:
Guiastrennec B; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Ramachandran G; National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chetpet, Chennai, India., Karlsson MO; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Kumar AKH; National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chetpet, Chennai, India., Bhavani PK; National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chetpet, Chennai, India., Gangadevi NP; National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chetpet, Chennai, India., Swaminathan S; National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chetpet, Chennai, India., Gupta A; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Dooley KE; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Savic RM; University of California San Francisco, San Francisco, California, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2018 Oct; Vol. 104 (4), pp. 733-741. Date of Electronic Publication: 2018 Feb 02.
Autor:
Guiastrennec B; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Sonne DP; Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.; Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, University of Copenhagen, Gentofte, Denmark., Bergstrand M; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.; Pharmetheus AB, Uppsala, Sweden., Vilsbøll T; Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, University of Copenhagen, Gentofte, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Knop FK; Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, University of Copenhagen, Gentofte, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Karlsson MO; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2018 Sep; Vol. 7 (9), pp. 603-612. Date of Electronic Publication: 2018 Aug 12.
Autor:
Guiastrennec B; Pharmacometrics Group, Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 75124, Uppsala, Sweden., Söderlind E; Pharmaceutical Technology and Development, AstraZeneca, Gothenburg, Sweden.; Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340, Beerse, Belgium., Richardson S; Advanced Drug Delivery, Pharmaceutical Sciences, Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Peric A; Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Bergstrand M; Pharmacometrics Group, Department of Pharmaceutical Biosciences, Uppsala University, Box 591, 75124, Uppsala, Sweden. martin.bergstrand@farmbio.uu.se.
Publikováno v:
Pharmaceutical research [Pharm Res] 2017 Apr; Vol. 34 (4), pp. 847-859. Date of Electronic Publication: 2017 Feb 02.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dotan, Or1 (AUTHOR) or.dotan@teva.co.il, Radivojevic, Andrijana2 (AUTHOR), Singh, Rajendra3 (AUTHOR)
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Oct2023, Vol. 12 Issue 10, p1375-1385. 11p.